Publications found:
118
Sort by:
Diabetic Neuropathy Market - 2023-2033
US$ 2,999.00
The Diabetic Neuropathy Market was valued at US$ 4.47 billion in 2023 and is anticipated to reach US$ 8.40 billion by 2033, at a CAGR of 0.066 from 2026 to 2032. The report delivers in-depth insights...
August 2025
207 pages
Diabetic Foot Ulcer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment (Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications, and Others), By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuroischemic Ulcers), By End User (Hospitals & Clinics, Ambulatory Care Centers, and Others), By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview Global Diabetic Foot Ulcer Treatment Market was valued at USD 5.51 billion in 2024 and is expected to reach USD 8.48 billion by 2030 with a CAGR of 7.45% during the forecast period. T...
August 2025
180 pages
Diabetic Ketoacidosis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Fluid Replacement Therapy, Electrolyte Replacement Therapy, Insulin Therapy, Others), By End User (Hospitals, Ambulatory Surgical Centers (ASCs), Homecare Settings), By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview The Global Diabetic Ketoacidosis Treatment Market was valued at USD 4.08 Billion in 2024 and is expected to reach USD 5.70 Billion by 2030 with a CAGR of 5.71%. The Global Diabetic Ke...
August 2025
183 pages
SGLT2 Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug (Jardiance, Farmiga, Inpefa, Invokana, Others), By Indication (Type 2 Diabetes, Cardiovascular, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview Global SGLT2 Inhibitors Market was valued at USD 15.37 Billion in 2024 and is expected to reach USD 21.44 Billion by 2030 with a CAGR of 5.90%. These oral antidiabetic agents have eme...
August 2025
185 pages
SGLT2 Inhibitors Market Size, Share & Trends Analysis Report By Drug (Jardiance, Farxiga, Inpefa, Invokana), By Indication (Type 2 Diabetes, Cardiovascular), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
SGLT2 Inhibitors Market The global SGLT2 inhibitors market size was estimated at USD 16.8 billion in 2024 and is projected to reach USD 28.9 billion by 2033, growing at a CAGR of 6.19% from 2025 to 20...
August 2025
150 pages
Diabetic Food Market Report by Product Type (Bakery Products, Dairy Products, Confectionery Products, Beverages, Snacks, Spreads, and Others), End Consumers (Children, Adults), Distribution Channel (Supermarkets and Hypermarkets, Drug Stores/Pharmacies, Grocery Stores, Online Stores, and Others), and Region 2025-2033
US$ 3,999.00
The global diabetic food market size reached USD 12.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 23.3 billion by 2033, exhibiting a growth rate (CAGR) of 6.47% durin...
August 2025
138 pages
Incretin-Based Drugs Market - 2024-2033
US$ 2,999.00
The Incretin-Based Drugs Market was valued at US$ 26.69 Billion in 2024 and is anticipated to reach US$ 42.42 Billion by 2033, at a CAGR of 0.056 from 2026 to 2032. The report delivers in-depth insigh...
July 2025
200 pages
Diabetes Therapeutics Market - 2023-2033
US$ 2,999.00
The Diabetes Therapeutics Market was valued at US$ 76.75 Billion in 2023 and is anticipated to reach US$ 321.96 Billion by 2033, at a CAGR of 0.154 from 2026 to 2032. The report delivers in-depth insi...
July 2025
223 pages
SGLT-2 Inhibitors Market - 2024-2033
US$ 2,999.00
The SGLT-2 Inhibitors Market was valued at US$ 17.95 billion in 2024 and is anticipated to reach US$ 32.16 billion by 2033, at a CAGR of 0.071 from 2026 to 2032. The report delivers in-depth insights...
June 2025
220 pages
Diabetic Food Market Size, Share, and Analysis By Product Type (Confectionery, Bakery Product, Dairy Product, Dietary Beverages, and Others), By Distribution Channel (Super Market, Hyper Market, and Grocery Stores, and Others), and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2023-2032
US$ 5,150.00
Diabetic Food Market Size, Share, and Analysis By Product Type (Confectionery, Bakery Product, Dairy Product, Dietary Beverages, and Others), By Distribution Channel (Super Market, Hyper Market, and G...
January 2024
461 pages
Global Diabetes Drug Market & Pipeline Insight 2015
US$ 2,400.00
... Global Diabetes Drug Market Overview Global Diabetic Drug Clinical Pipeline by Company & Phase Global Diabetic Drug Clinical Pipeline: 817 Drugs Majority in Preclinical Phase: 205 Drugs Type 2 Diabetes Mellitus Drugs in Pipeline: 380 Drugs Type 1 Diabetes Mellitus Drugs in Pipeline: 79 Drugs Diabetic ...
April 2015
1100 pages
